The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Regulation of Insulin Action by Ceramide
Open accessAbstract
The sphingolipid ceramide negatively regulates insulin action by inhibiting Akt/protein kinase B (PKB), a serine/threonine kinase that is a central regulator of glucose uptake and anabolic metabolism. Despite considerable attention, the molecular mechanism accounting for this action of ceramide has remained both elusive and controversial. Herein we utilized deletion constructs encoding two different functional domains of Akt/PKB to identify which region of the enzyme conferred responsiveness to ceramide. Surprisingly the findings obtained with these separate domains reveal that ceramide blocks insulin stimulation of Akt/PKB by two independent mechanisms. First, using the isolated pleckstrin homology domain, we found that ceramide specifically blocks the translocation of Akt/PKB, but not its upstream activator phosphoinositide-dependent kinase-1, to the plasma membrane. Second, using a construct lacking this pleckstrin homology domain, which does not require translocation for activation, we found that ceramide stimulates the dephosphorylation of Akt/PKB by protein phosphatase 2A. Collectively these findings identify at least two independent mechanisms by which excessive ceramide accumulation in peripheral tissues could contribute to the development of insulin resistance. Moreover the results obtained provide a unifying theory to account for the numerous dissenting reports investigating the actions of ceramide toward Akt/PKB.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lipotoxicity is characterized by the accumulation of lipid metabolites (ceramides and diacylglycerol) that interfere with insulin signaling, thus impairing insulin action (26,28).”
From Metabolic flexibility to lipid availability during exercise is enhanced in individuals with high insulin sensitivity (2018) · cites this paper as [26]
Citations
Cites
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
The sphingomyelin cycle and the second messenger function of ceramide.
Hannun, Y. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41834-5 · Cited by 1,235
The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind
Hannun, Y. A., & Obeid, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200008200 · Cited by 907
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Signal transduction of stress via ceramide
MATHIAS, S., PEÑA, L. A., & KOLESNICK, R. N. (1998) · Biochemical Journal · doi:10.1042/bj3350465 · Cited by 682
Role of Akt/protein kinase B in metabolism
Whiteman, E. L., Cho, H., & Birnbaum, M. J. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00662-8 · Cited by 676
Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Adams, J. M., Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., & Mandarino, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.25 · Cited by 668
Ceramide activates heterotrimeric protein phosphatase 2A
Dobrowsky, R. T., Kamibayashi, C., Mumby, M. C., & Hannun, Y. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82288-8 · Cited by 665
Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617
Self-citation
Research works printed but not linked: 4
- Dobrzyn, 2002, Am. J. Physiol., 282, E277
- Wang, 2003, Methods Mol. Med., 83, 127
- Gray, 1999, Biochem. J., 344, 929, 10.1042/bj3440929 · doi:10.1042/bj3440929 · Paper page
- Jarvis, 1996, Clin. Cancer Res., 2, 1
Cited by
Items 301–400 of 427
Rigamonti, A. E., Dei, M., Caroli, D., Col, A. D., Cella, S. G., Paroni, R. C., & Sartório, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087451 · Cited by 11
“Activation of PP2A causes dephosphorylation at T308 that inactivates AKT [51], while PKCξ, activated by Cer, phosphorylates T34 in a specific domain of AKT, preventing phosphatidylinositol-3,4,5-triphosphates (PIP3) from binding, and inhibiting AKT translocation and subsequent activation in response to insulin [51,52].”
BackgroundPollak, N., Janežič, E. G., Šink, Ž., & Ugwoke, C. K. (2025) · Metabolites · doi:10.3390/metabo15090581 · Cited by 13
“…ceramides either activate protein phosphatase 2A (PP2A), which dephosphorylates AKT at Thr308/Ser473, or induce atypical protein kinase C (aPKC λ / ζ ) activity, which interferes with AKT’s membrane translocation and binding to phosphatidylinositol (3,4,5)-trisphosphate (PIP3) [235,236].”
Takagi, H., Ikehara, T., Hashimoto, K., Tanimoto, K., Shimazaki, A., Kashiwagi, Y., Sakamoto, S. X., & Yukioka, H. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174451 · Cited by 11
You aren't IMMUNE to the ceramides that accumulate in cardiometabolic disease
Varre, J. V., Holland, W. L., & Summers, S. A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159125 · Cited by 13
Self-citationTargeting Ceramides and Adiponectin Receptors in the Islet of Langerhans for Treating Diabetes
Li, W. (2022) · Molecules · doi:10.3390/molecules27186117 · Cited by 11
Autophagy modulators in type 2 diabetes: A new perspective
Zaidalkilani, A. T., Al-Kuraishy, H. M., Fahad, E. H., Al-Gareeb, A. I., Elewa, Y. H. A., Zahran, M. H., Alexiou, A. T., Papadakis, M., AL-Farga, A. M., & Batiha, G. E. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.70010 · Cited by 11
Embryonic expression of Drosophila ceramide synthase schlank in developing gut, CNS and PNS
Voelzmann, A., & Bauer, R. (2011) · Gene Expression Patterns · doi:10.1016/j.gep.2011.08.006 · Cited by 11
Mansuri, M. L., Sharma, G., Parihar, P., Dube, K. T., Sharma, T., Parihar, A., & Parihar, M. S. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22744 · Cited by 11
Xu, K., Shi, L. S., Zhang, B., Mi, B., Yang, J., Sun, X., Liao, X., Dai, X., Zeng, L., Liu, X., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.03.025 · Cited by 10
Energy metabolism and redox balance: How phytochemicals influence heart failure treatment
Chen, C., Wang, J., Zhu, X., Hu, J., Liu, C., & Liu, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116136 · Cited by 10
Zhao, Y., Zhao, H., Li, L., Yu, S., Liu, M. R., & Jiang, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1321597 · Cited by 11
Clinical effects of high-fat meals and weight gain due to high-fat feeding
Gupta, N., & Jensen, M. D. (2012) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2012.23 · Cited by 10
Bae, J. C., Wander, P. L., Lemaître, R. N., Fretts, A. M., Sitlani, C. M., Bui, H. H., Thomas, M. K., Leonetti, D. L., Fujimoto, W. Y., Boyko, E. J., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.10.026 · Cited by 9
Tang, J., Yan, Y., Li, J., Yang, B., Zhao, X., Wan, Y., Zheng, J., Mi, J., & Li, D. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.09.013 · Cited by 9
Exploring Ceramide C16:0 as a Novel Biomarker and Therapeutic Target for Atherosclerosis
Chen, T., Xie, L., Zhao, Y., Shang, Y., Pan, Y., Wang, W., & Mao, W. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.044903 · Cited by 8
Tarlton, J., Patterson, S., & Graham, A. (2021) · Biology · doi:10.3390/biology10060534 · Cited by 8
“These changes reflect altered cell signalling pathways, increased expression of inflammatory cytokines, lipogenic and pro-apoptotic genes and proteins, and the accumulation of lipids, including diacylglycerols and triacylglycerols, ceramides, cholesterol and cholesteryl esters [42,52].”
BackgroundBrands, M., van Raalte, D. H., Ferraz, M. J., Sauerwein, H. P., Verhoeven, A. J., Aerts, J. M. F. G., Diamant, M., & Serlie, M. J. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3266 · Cited by 8
Schomakers, B. V., Passadouro, A. S., Trętowicz, M. M., Simpson, P. J., Jaspers, Y. R. J., van Weeghel, M., Hu, I. M., Lamboo, C. M. E., Cloutier, D., Byrne, B. J., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00320-5 · Cited by 7
Roszczyc-Owsiejczuk, K., Imierska, M., Sokołowska, E., Kuźmicki, M., Pogodzińska, K., Błachnio-Zabielska, A. U., & Zabielski, P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307802 · Cited by 7
Alzheimer’s Disease in Diabetic Patients: A Lipidomic Prospect
Makki, B. E., & Rahman, S. B. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.08.033 · Cited by 8
TREM2 as a Therapeutic Target in Atherosclerosis
Xu, S., Yang, B., Yu, W., Gao, Y., Cai, H., & Wang, Z. (2025) · Cell Biology International · doi:10.1002/cbin.12279 · Cited by 7
Contribution Of Sphingolipids To The Pathogenesis Of Obesity
Samad, F. (2007) · Future Lipidology · doi:10.2217/17460875.2.6.625 · Cited by 8
Ceramide microdomains: the major influencers of the sphingolipid media platform
Weber-Stout, M., Nicholson, R. J., Dumaguit, C. D. C., Holland, W. L., & Summers, S. A. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231395 · Cited by 6
Self-citationGT-11 impairs insulin signaling through modulation of sphingolipid metabolism in C2C12 myotubes
Rustamov, J., Roh, Y., Hong, J. T., & Yoo, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122534 · Cited by 6
Associations between Serum Saturated Fatty Acids Content and Mortality in Dialysis Patients
Sikorska-Wiśniewska, M., Mika, A., Śledziński, T., & Chmielewski, M. S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175051 · Cited by 6
The two Cs: ceramide and cardiomyopathy
Getz, G. S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.e800015-jlr200 · Cited by 6
“Park et al. (1) noted an increase in pAKT and its downstream target G3K-3b, which upon phosphorylation promotes glycogen synthesis.”
BackgroundUltrafast Measurement of Circulating Ceramides in Human Cohorts
Tham, W. K., Chang, J. K., Teo, G., Vasile, V. C., Meeusen, J. W., Ekroos, K., Futerman, A. H., Kuan, W. S., Choi, H., Wenk, M. R., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00058 · Cited by 5
Lipidomic profiling unveils sex differences in diabetes risk: Implications for precision medicine
Pina, A. F., Meneses, M. J., Carli, F., Patrício, B., Ribeiro, R. T., Patarrão, R. S., Gardete-Correia, L., Duarte, R., Boavida, J. M., Raposo, J. F., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70137 · Cited by 8
“43 Additionally, elevated sphingomy-elins in this cluster may contribute to or be influenced by ceramide levels.”
Lipotoxicity damage of myocardium in obesity
Гриценко, О. В., Chumakova, G. A., Elchaninova, S. A., Veselovskaya, N. G., Shevlyakov, I. V., & Kalugina, O. A. (2017) · Cardiosomatics · doi:10.26442/cs45386 · Cited by 5
Osteosarcopenia as a Lipotoxic Disease
Saedi, A. A., Goodman, C. A., Myers, D. E., Hayes, A., & Duque, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-25890-0_6 · Cited by 4
Metabolic Syndrome as a Risk Factor for Alzheimer Disease
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_8 · Cited by 5
Ribel-Madsen, A., Ribel‐Madsen, R., Nielsen, K. F., Brix, S., Vaag, A. A., & Brøns, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-21419-5 · Cited by 5
“Thus, these lipids inhibit the phosphorylation and thereby activation of Akt/protein kinase B (PKB) of the insulin signalling cascade, which is a central regulator of glucose and amino acid uptake, anabolic processes, and cell survival 28,29 .”
BackgroundRole of Ceramide 1-Phosphate in the Regulation of Cell Survival and Inflammation
Ouro, A., Arana, L., Gangoiti, P., & Gómez‐Muñoz, A. (2012) · InTech eBooks · doi:10.5772/32849 · Cited by 4
“…protein phosphatase 2A and the subsequent dephosphorylation and inactivation of protein kinase B (PKB) (Schmitz-Peiffer, 2002; Adams et al., 2004; Stratford et al., 2004), and toll-like receptor 4 (TLR4)-dependent induction of inflammatory cytokines, a fact essential for TLR4-dependent insulin…”
BackgroundInsulin Signaling in Cardiac Health and Disease
Bartlett, J., Trivedi, P. C., & Pulinilkunnil, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803111-7.00012-9 · Cited by 4
The Potential Role of Retinol-Binding Protein 4 in Heart Failure: A Review
Liu, J., & Wang, Y. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm40127 · Cited by 4
Insulin Resistance and Cardiometabolic Syndrome
Kim, J. (2021) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2021.1.e9 · Cited by 6
Interaction between Lipid Availability, Endurance Exercise and Insulin Sensitivity
Newsom, S. A., & Schenk, S. (2014) · Medicine and sport science/Medicine and sport · doi:10.1159/000357336 · Cited by 3
Fenger, M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.11.018 · Cited by 4
“Ceramide impairs insulin signalling by inhibition of protein kinase B (PKB) [14], and the stimulation of ceramidase by adiponectin improves the insulin signalling e which just does not happen in fulminant diabetic mellitus type 2 because of the low levels of adiponectin.”
BackgroundEditorial: Lipotoxicity, mitotoxicity, and drug targets
Jakovljevic, N. K., Boardman, N. T., & Makrecka‐Kuka, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1245111 · Cited by 3
Negretti-Borga, D. M., Teixeira, M. P., Blanco, A., Puentes, E. N., Soler, M. F., Alamino, V. A., Donadío, A. C., Clarke, C. J., Montesinos, M. D. M., Hannun, Y. A., et al. (2026) · Journal of Endocrinology · doi:10.1530/joe-26-0081 · Cited by 2
Lipidomic Changes in Skeletal Muscle in Patients after Biliopancreatic Diversion
Mehnert, C. S., Graessler, J., Kamvissi, V., Castagneto‐Gissey, L., Mariolo, J. R. C., Casella, G., Mingrone, G., & Bornstein, S. R. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-120065 · Cited by 2
Ting, K. K. Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1407108 · Cited by 2
Insulin Mechanisms/Metabolic Actions
Gallagher, E. J., & LeRoith, D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00116-x · Cited by 2
Investigating a New Way to Assess Metabolic Risk in Pregnant Females with Prior RYGB Surgery
Gisinger, T., Reiter, B., Preindl, K., Stimpfl, T., Gard, L.-I., Baumgartner-Parzer, S. M., Kautzky‐Willer, A., & Leutner, M. (2024) · Nutrients · doi:10.3390/nu16162704 · Cited by 1
“…the action of the anabolic enzyme Akt or protein kinase B, which is an insulin-stimulated kinase that acts in the liver by reducing gluconeogenesis, increases the glucose uptake in muscle and adipose tissue, and further represses the production of glucagon in pancreatic alpha-cells [18,28,29].”
BackgroundEP4: A prostanoid receptor that modulates insulin signalling in rat skeletal muscle cells
Nisr, R. B., Shah, D. S., & Hundal, H. S. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111516 · Cited by 1
The regulatory role of exercise in heart failure and myocardial energy metabolism: A review
Li, Y., Gao, D., Li, P., Duan, X., Liu, Y., Wu, C., Wang, L., & Wang, X. (2025) · Biomolecules and Biomedicine · doi:10.17305/bb.2025.12072 · Cited by 1
Lipidomic Signatures in Pediatric Metabolic Disorders
Narváez-Rivas, M., & Setchell, K. D. R. (2025) · Metabolites · doi:10.3390/metabo16010033 · Cited by 1
“Another hallmark finding is the accumulation of ceramides [43], a class of sphingolipids known to disrupt insulin signaling through the activation of protein kinase C (PKC) isoforms and inhibition of Akt phosphorylation [44].”
Emerging complexities of phospholipid metabolism in adipose tissue
Kim, M., Lee, H., Heeren, J., Kim, J., Lee, G., & Jung, S. M. (2026) · Molecules and Cells · doi:10.1016/j.mocell.2026.100333 · Cited by 2
“This occurs via activation of protein kinase C zeta, which inhibits Akt membrane recruitment, or through protein phosphatase 2A activation, which dephosphorylates Akt, thereby disrupting insulin signaling (Powell et al., 2003; Stratford et al., 2004; Stretton et al., 2010).”
VanCleave, A. M., Sunilkumar, S., Toro, A. L., Kimball, S. R., & Dennis, M. D. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.110957 · Cited by 1
Gaggini, M., Suman, A. F., & Vassalle, C. (2026) · Metabolites · doi:10.3390/metabo16040265 · Cited by 1
“First, it specifically blocks the translocation of Akt/PKB, but not its upstream activator phosphoinositide-dependent kinase-1, to the plasma membrane, and the second mechanism reveals that ceramide stimulates the dephosphorylation of Akt/PKB by protein phosphatase 2A [26].”
Duan, X., Davis, L. M., Patel, S., Bidault, G., Long, L., Jenkins, B., Yi, Y., Pushpa, P., Wesseling, J. R., Koulman, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed0535 · Cited by 1
Gastaldelli, A., Choi, E., Conde‐Knape, K., Göransson, O., Krook, A., Lehtonen, S. H., Roden, M., Schrauwen, P., Sparks, L. M., & Heni, M. (2026) · Diabetologia · doi:10.1007/s00125-026-06853-9 · Cited by 3
Farooqui, A. A., & Farooqui, T. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch7 · Cited by 2
Insulin resistance and Alzheimer’s disease
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00006-7 · Cited by 1
Insulin resistance and obesity
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00001-8 · Cited by 1
Sphingolipid mediators of cell signaling and metabolism
Dobrzyń, A., Janikiewicz, J., Tracz‐Gaszewska, Z., Filip, A., Dobosz, A. M., Krogulec, E., & Dobrzyń, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00019-1 · Cited by 1
Effects of cellular lipids on heart in pathology and physiology
Balatskyi, V. V., Wołosiewicz, M., Dobosz, A. M., Tracz‐Gaszewska, Z., Sówka, A., Kendziorek, M., Krogulec, E., Navrulin, V. O., & Dobrzyń, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95582-9.00003-6 · Cited by 3
Lipid Mediators in Metabolic Syndrome and Neurological Disorders
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_4 · Cited by 1
Studies of the interaction between diabetes family history, exercise, adiposity and metabolic health
Barwell, N. D. (2010) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Early modification of the adipose tissue linking obesity and metaflammation
Caputo, T. (2019) · IRIS · Cited by 1
Regulation | Insulin Mechanisms/Metabolic Actions
Gallagher, E. J., & LeRoith, D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00580-6 · Cited by 1
Characterisation of the first specific inhibitor of ceramide synthase 1
Lim, X. Y. (2018) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/20452 · Cited by 1
Campello, R. S. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2009.tde-01072009-121431
Lipid Products and Cell Signaling
WARDLE, E. N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-538-5_7
Insulin sensitivity of hepatic glucose and lipid metabolism in animal models of hepatic steatosis
Grefhorst, A. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Studies on the role of glycosphingolipids in metabolism
Langeveld, M. (2009) · UvA-DARE (University of Amsterdam) · Cited by 1
Ceramide, a crucial functional lipid, and its metabolic regulation by acid ceramidase
Park, J., & Yoon, S. H. (2010) · Food Science and Biotechnology · doi:10.1007/s10068-010-0122-y
“Akt/protein kinase B, a central regulator of glucose uptake and anabolic metabolism, leading to insulin resistance ( 61 ).”
BackgroundInvestigation of the relationship between sphingolipid and insulin signaling pathways
Karagoz, K., & Ülgen, K. Ö. (2010) · National Biomedical Engineering Meeting · doi:10.1109/biyomut.2010.5479799
“Örneğin, seramidin, hücreye glikoz alımını ve anabolik metabolizmayı kontrol eden, insülin sinyal ağında merkezi konumda bulunan AKT/protein kinaz B(PKB)’nin fosforlanmasını ve aktive olmasını engellediği belirlenmiştir [1, 2] Amacımız, sfingolipid ve insülin sinyal ağları arasındaki ilişkinin kurulmasında rol alan pr…”
Glycosphingolipids and atherosclerosis
Lombardo, E. (2013) · UvA-DARE (University of Amsterdam)
Ferrara, C. T. (2008) · DukeSpace (Duke University)
Kim, C. K., Sinclair, A. J., Febbraio, M. A., Watt, M. J., Lee, J. S., Pinnamaneni, S. K., Pyo, J. H., Kuo, M., Bilan, P. J., Klip, A., et al. (2015)
Pathways controlling metabolic and hypertrophic responses in skeletal muscle
Riedl, I. (2015) · Figshare
Vascular endothelial growth factor B-role in metabolism, lipotoxicity and disease
Mehlem, A. (2015) · Figshare
WARDLE, E. N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-538-5_11
Rebuttal from Scott A. Summers and Bret H. Goodpaster
Summers, S. A., & Goodpaster, B. H. (2016) · The Journal of Physiology · doi:10.1113/jp272136 · Cited by 1
Self-citationThe impact of glucocorticoids upon the insulin sensitivity of skeletal muscle
Morgan, S. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 2
Effects of high-fat feeding on skeletal muscle insulin signalling in sarcolipin knockout mice
Sayer, R. A. (2010) · UWSpace (University of Waterloo) · Cited by 1
Can sedentary time attenuate the acute effect of exercise on insulin action
Wilson, M. E. (2014) · QSpace (Queen's University Library)
Mass Spectrometry in the Analysis of Fatty Acids and Derivatives
Lin, Y. H., Guan, M., Li, L., Zhang, Y., & Zhao, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809521-8.00018-0
Vlavcheski, F. (2018) · Brock University Digital Repository (Brock University)
Effects of testosterone levels on mortality and cardiovascular risk in men with Type 2 diabetes
Muraleedharan, V. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
An exploration into the proteins that regulate skeletal muscle lipid metabolism
Whytock, K. L. (2021) · Liverpool John Moores University · doi:10.24377/ljmu.t.00009962 · Cited by 2
The Regulation of Adipose Tissue and Skeletal Muscle Substrate Metabolism by Ghrelin
Cervone, D. T. (2020) · The Atrium (University of Guelph)
The effects of lipid availability on skeletal muscle metabolism in lean and obese rodents and humans
Thrush, A. B. (2010) · The Atrium (University of Guelph)
Characterizing the Mechanisms of Insulin Resistance in Dairy Cattle
Davis, A. N. (2017) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7075
Sphingolipides : nouveaux régulateurs de la masse et de la fonction musculaire ?
Lair, B. (2023) · theses.fr (ABES) · doi:10.70675/47a64499zee05z4065z9ee5z7c0c891477ec
BIological and Pathophysiological Significance of De Novo Ceramide Biosynthesis Enzymes
Belik, E. V., Dyleva, Y. A., & Gruzdeva, O. V. (2023) · Успехи физиологических наук · doi:10.31857/s0301179823010046
Role of stearoyl-CoA desaturase1 in fatty acid-induced insulin resistance
Pinnamaneni, S. (2011) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27340278
Anti-diabetic effects of oleanolic acid and matrine
Zeng, X. (2014) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27351540
Effects of dairy proteins and calcium on diet-induced obesity in mice
Pilvi, T. K. (2008) · Työväentutkimus Vuosikirja
Obesity mediated dysregulation in the expression and action of myostatin
Wilhelmsen, A. (2022) · Nottingham ePrints (University of Nottingham) · Cited by 2
Mechanisms of Lipotoxicity by Palmitate in ß-cells
Yung, J. H. M. (2021) · TSpace (University of Toronto)
García Beltran, C. (2024) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Detergents without a drain: the evolutionary logic (and liability) of sphingolipids
Summers, S. A. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.100998
Self-citationd-Threitol alleviates symptoms of diabetes in db/db mice by reducing hepatic ceramide levels
Li, Q., Xu, S., Li, T., Lin, C. S. K., & Cheng, H. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107261
Étude du rôle de la production hépatique de glucose dans le développement du diabète et de l’obésité
Abdul-Wahed, A. (2012) · theses.fr (ABES) · doi:10.70675/61924053za287z4f04zb650zc51c1916ee64
Ngo, K. T. A. (2013) · theses.fr (ABES) · doi:10.70675/20e1b267z2d39z4486z8d2dz0bf20c86d076 · Cited by 1
Metadata
- Authors
- Stratford, S., Hoehn, K. L., Liu, F., & Summers, S. A.
- Affiliations
- Colorado State University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Summers, Scott A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 279
- Issue
- 35
- Pages
- 36608-36615
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1995687483
- Cited by
- 410
- References
- 60
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 21 · 2023: 12 · 2022: 16 · 2021: 21 · 2020: 27 · 2019: 21 · 2018: 21 · 2017: 26 · 2016: 21 · 2015: 17 · 2014: 11 · 2013: 24 · 2012: 24
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5921 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R012 DK 58784, R01DK056166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- ceramide, insulin resistance, Akt/protein kinase B, pleckstrin homology domain, PDPK1, protein phosphatase 2A, Akt dephosphorylation, sphingolipids, glucose uptake, insulin signaling
- MeSH terms
- Animals, Cell Line, Cell Membrane, Ceramides, Enzyme Inhibitors, Gene Expression Regulation, Insulin, Microscopy, Fluorescence, Phosphorylation, Proto-Oncogene Proteins, Immunoblotting, Signal Transduction, Protein Serine-Threonine Kinases, Gene Deletion, Protein Structure, Tertiary, DNA, Complementary, Microscopy, Confocal, Okadaic Acid, Phosphatidylinositol 3-Kinases, Catalytic Domain, Protein Transport, 3T3-L1 Cells, Proto-Oncogene Proteins c-akt, Mice, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.